RHCT-138細(xì)胞
ATCC Number： CRL-2563?
器官來(lái)源： 皮膚
相關(guān)**： 其他**
生長(zhǎng)狀態(tài)： 懸浮生長(zhǎng)，多細(xì)胞聚集
運(yùn)輸方式： 凍存運(yùn)輸
細(xì)胞類(lèi)型： 其他細(xì)胞類(lèi)型
是否是腫瘤細(xì)胞： 0
物種來(lái)源： 其他
年限： 4.5 years
數(shù)量： 大量
RHCT-138細(xì)胞細(xì)胞形態(tài)： **樣
Designations: RHCT-138
Depositors: RM Simpson
Biosafety Level: 2 [Cells infected with HTLV-I virus ]
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: suspension, multicell aggregates
Organism: Oryctolagus cuniculus deposited as rabbit
Morphology: lymphoblast
Source: Organ: skin
Disease: cutaneous T cell lymphoma
Cell Type: infected with HTLV-I
Cellular Products: RHCT-138細(xì)胞HTLV-I (human T cell leukemia virus)
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Restrictions: 1. This cell line was deposited at the ATCC by Dr. R. Mark Simpson and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied. 2. Any proposed commercial use of these cells, or their products must first be negotiated with the National Institute of Allergy and Infectious Diseases (NIAID) Office of Technology Development (OTD), Building 31, Room 3B-62 31 Center Drive, MSC 2137 Bethesda, MD 20892-2137 TEL: 301-496-2644 FAX: 301-402-7123
Isolation: Isolation date: February, 1997
Age: 4.5 years
Gender: male
Comments: RHCT-138細(xì)胞The RHCT-138 cell line was derived from a skin biopsy taken from an HTLV-1 infected rabbit (X138) with cutaneous T cell lymphoma (CTCL). [50754]
The rabbit developed chronic HTLV-1 infection after inoculation with the infected rabbit T cell line RH/K34 (see ATCC CRL-2560). [50754]
Approximately 20 months after inoculation, the rabbit developed a generalized exfoliative papillated dermatopathy. Cutaneous lesions were biopsied. [50754]
The cell line harbors productively infected, monoclonally integrated, full length HTLV-1.
The HTLV-1 sequences in the skin likely represent the presence of infected T cells in epidermotropic lymphoid infiltrates. [50754]
Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate supplemented with an additional 2 mM L-glutamine, 80%; fetal bovine serum, 20%
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37.0°C
Subculturing: Protocol: Cultures can be maintained by addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension in fresh medium at 5 X 10(5) viable cells/ml.
Interval: Maintain cultures at cell concentrations between 5 X 10(5) and 2 X 10(6) viable cells/ml.
Medium Renewal: RHCT-138細(xì)胞Every 2 to 3 days
Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
References: 50754: Simpson RM, et al. Cutaneous manifestations of human T cell leukemia virus type I infection in an experimental model. J. Infect. Dis. 173: 722-726, 1996. PubMed: 8627039
53506: Kindt TJ, et al. Passage of human T-cell leukemia virus type-1 during progression to cutaneous T-cell lymphoma results in myelopathic disease in an HTLV-1 infection model. Microbes Infect. 2: 1139-1146, 2000. PubMed: 11008104
